Current filters:


Popular Filters

7950 to 7974 of 8448 results

Novel approach for multiple sclerosis treatment identified by Biogen Idec


US biotech firm Biogen Idec (Nasdaq: BIIB) has revealed results from a study that suggest that inhibiting…

Biogen IdecBiotechnologyNeurologicalPharmaceuticalResearch

Government of Zambia provides incentives for pharma industry


The Zambian government last week introduced incentives aimed at protecting the local steel-iron and pharmaceutical…

GenericsRegulationRest of the World

Novartis gets US and Japanese approval for COPD drug Arcapta/Onbrez


In two pieces of good news for Swiss drug major Novartis (NOVN: VX) on Friday, the company announced…

ArcaptaAsia-PacificNorth AmericaNovartisOnbrezPharmaceuticalRegulationRespiratory and Pulmonary

EU Commission's research funding plans slammed by scientists and NGOs


In an open letter sent last week to the President and Members of the European Commission, as well as…


Boost for Dendreon, as CMS to cover Provenge treatment and FDA OKs production facility


There was a batch of good news for Seattle, USA-based Dendreon (Nasdaq: DNDN) that support broad availability…

BiotechnologyDendreonNorth AmericaOncologyPharmaceuticalPricingProvengeRegulation

UK NICE says benefits of breast cancer drugs Tyverb and Herceptin still unproven


In a draft guidance issued last Friday, the UK’s drug watchdog, the National Institute for Health…


Australian government report on inappropriate use of intellectual property rights in medicines


The Australian government last week tabled its report to Parliament on barriers to medicines entering…


Novartis COPD drug candidate NVA237 superior to placebo and similar to tiotropium in Ph III


Swiss drug major Novartis (NOVN: VX) has announced positive results from the pivotal Phase III GLOW2…

NovartisPharmaceuticalResearchRespiratory and PulmonarySoseiVectura

US NDA filings for Vivus’ ED drug avanafil and Corcept’s Corlux for Cushing’s


California, USA-based Vivus (Nasdaq: VVUS) has submitted a New Drug Application has to the Food and Drug…

avanafilCorluxNorth AmericaPharmaceuticalRare diseasesRegulationReproductiveVivus

Pfizer and ChemRar plan to explore innovative R&D partnership in Russia


Following in the footsteps of Switzerland’s Roche, global drugs behemoth Pfizer (NYSE: PFE) has…

Cardio-vascularChemRar Hi-TechOncologyPfizerPharmaceuticalResearch

Doctors tell US FDA: “HIV prevention pill” - Gilead's Truvada - not ready for approval


Last week, a group of 55 US physicians sent a letter to the Food and Drug Administration urging the agency…

Anti-viralsGilead SciencesNorth AmericaPharmaceuticalRegulationTruvada

Novartis’ Gilenya has begun to impact established DMAs and market perceptions; report


While physician trialing of Swiss drug major Novartis’ (NOVN: VX) Gilenya (fingolimod), the first…

GilenyaMarkets & MarketingNeurologicalNovartisPharmaceutical

Pennsylvania Bio collaborates with Italian biotech association


The USA’s Pennsylvania Bio, the only state-wide trade association representing Pennsylvania’s…

BiotechnologyEuropeNorth AmericaResearch

Canada falling back on innovation performance, says STIC


Canada’s innovation performance has slumped on most key measures over the past two years, according…

North AmericaPatentsPharmaceuticalResearch

Bayer and Regeneron file for Japanese approval of wet AMD drug Eylea


Following swiftly on receiving a strong backing for the product from a US Food and Drug Administration…

Asia-PacificBayerEyleaOphthalmicsPharmaceuticalRegeneronRegulationVEGF Trap-Eye

7950 to 7974 of 8448 results

Back to top